|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 07/05/15 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 30/04/15 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.31B | |
| +1.94% | -2.38% | -4.74% | +1.87% | +15.54% | +21.83% | +77.12% | +225.93% | +5,388.40% | 56.95B | |
| +2.54% | +1.13% | +5.35% | +1.76% | +9.82% | +5.99% | +37.67% | -15.58% | +217.19% | 48.3B | |
| +0.50% | +2.94% | -1.11% | +9.74% | +160.74% | +344.62% | +722.17% | +640.92% | - | 44.51B | |
| +3.05% | -1.80% | -0.63% | +28.52% | +18.05% | +28.78% | +34.51% | +11.17% | +230.38% | 43.8B | |
| +1.00% | -1.46% | +0.95% | +21.50% | +19.04% | +5.17% | +111.90% | +4.12% | +1,041.57% | 41.12B | |
| -0.54% | +2.41% | -2.92% | -0.54% | +5.93% | +9.31% | +58.85% | +1.88% | +144.91% | 31.07B | |
| +4.51% | +8.22% | +19.43% | +53.17% | +84.16% | +37.86% | +32.49% | -49.91% | - | 28.97B | |
| +0.76% | -1.45% | -5.90% | +0.10% | +2.56% | -7.44% | -11.12% | -60.96% | - | 24.53B | |
| -6.56% | -11.76% | -17.78% | -6.96% | -40.34% | -33.93% | +314.66% | +291.22% | +588.07% | 22.67B | |
| +8.77% | +11.52% | +20.69% | +41.40% | +27.48% | +21.94% | +3.82% | -7.22% | +127.46% | 21.31B | |
| +3.51% | +0.74% | +4.94% | +11.28% | +10.48% | +16.53% | +154.23% | +221.01% | +1,960.81% | 17.32B | |
| +2.15% | +3.03% | -9.16% | -5.37% | +180.86% | +136.14% | +351.43% | +1,738.00% | +664.96% | 15.53B | |
| +0.07% | -0.88% | -15.72% | -16.93% | - | - | - | - | - | 14.98B | |
| +3.60% | +2.70% | +9.30% | +13.92% | +25.42% | +25.94% | +47.83% | -27.17% | +90.37% | 14.7B | |
| +0.79% | +0.82% | -0.27% | +5.37% | +34.27% | +46.79% | +165.81% | +181.44% | +348.55% | 14.58B | |
| +1.75% | +1.06% | -2.53% | -8.69% | +21.88% | -14.87% | +519.17% | - | - | 14.31B | |
| +7.09% | +5.49% | +7.72% | +34.71% | +55.79% | +75.25% | +62.58% | -22.57% | +274.56% | 14.84B | |
| +9.03% | -1.80% | +29.29% | +38.63% | +41.49% | -8.85% | - | - | - | 15.08B | |
| Average | +2.08% | -0.36% | +2.40% | +13.59% | +42.10% | +42.25% | +163.37% | +196.36% | +923.10% | 27.94B | |
| Weighted average by Cap. | +2.16% | -0.60% | +2.38% | +15.59% | +44.79% | +49.92% | +152.77% | +152.21% | +1,302.20% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
